Piperazine, 1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, cis-
CAS: 65277-42-1
Rif. AN-AG00352N
1g | Fuori produzione | ||
5g | Fuori produzione | ||
10g | Fuori produzione | ||
25g | Fuori produzione |
- Eterocicli a 5 termini
- Composti correlati al principio attivo farmaceutico (API)
- Principi attivi farmaceutici (API) per la ricerca
- Antimicotici
- Prodotti biochimici e reagenti
- Ricerca sul cancro
- Biologia cellulare e molecolare
- Diossolano
- Attivatori e inibitori enzimatici
- Eterocicli con azoto (N)
- Imidazoli
- Altri inibitori
Informazioni sul prodotto
Nome:
Piperazine, 1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, cis-
Sinonimi:
- [u'Ketoconazole', u'Nizoral', u'R 41400', u'R-41400', u'R41,400', u'R41400', u'ketoconazole', u'65277-42-1', u'Extina', u'Xolegel', u'(+)-Ketoconazole', u'Nizoral', u'Kuric', u'(2R,4S)-ketoconazole', u'Ketocanazole', u'Ketoconazol', u'Fungarest', u'Fungoral', u'Ketoderm', u'C26H28Cl2N4O4', u'CPD000058460', u'CHEMBL75', u'MFCD00058579', u'R-41400', u'Ketoconazolum', u'SMR000058460', u'MLS000069784', u'MLS001146934', u'1-acetyl-4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine', u'CHEBI:48336', u'NSC 317629', u'DSSTox_CID_9879', u'DSSTox_RID_78829', u'DSSTox_GSID_29879', u'1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone', u'142128-59-4', u'HSDB 7447', u'R 41400', u'EINECS 265-667-4', u'KW-1414', u'rac-trans-Ketoconazole', u'BRN 4303081', u'1-(4-(4-(((2R,4S)-2-((1H-IMIDAZOL-1-YL)METHYL)-2-(2,4-DICHLOROPHENYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZIN-1-YL)ETHANONE', u'KTZ', u'SR-01000075626', u'SR-01000597381', u'Ketoconazole (k)', u'Ketoconazole,(S)', u'NCGC00016907-01', u'(+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine', u'cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine', u'DRG-0073', u'KCZ', u'KTN', u'Prestwick_744', u'Ketoconazole [USAN:INN:BAN:JAN]', u'CAS-65277-42-1', u'Tocris-1103', u'Opera_ID_397', u'Prestwick0_000389', u'Prestwick1_000389', u'Prestwick2_000389', u'Prestwick3_000389', u'R 41,400', u'UPCMLD-DP138', u'R41400', u'AC1L9UG3', u'SCHEMBL8407', u'Lopac0_000666', u'R41,400', u'BSPBio_000577', u'MLS000758224', u'MLS001423987', u'MLS002207053', u'MLS002222255', u'BIDD:GT0696', u'US9150527, Ketoconazole', u'SPBio_002498', u'BDBM8610', u'BPBio1_000635', u'DTXSID7029879', u'UPCMLD-DP138:001', u'BDBM60666', u'HY-B0105A', u'Ketoconazole, >=98% (HPLC)', u'HMS1569M19', u'HMS2051A19', u'HMS2089N05', u'HMS2096M19', u'HMS2234H17', u'HMS3262E13', u'HMS3678J17', u'HMS3713M19', u'ZINC643138', u'CIS-1-ACETYL-4-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZINE', u'Piperazine, (+/-)-1-acetyl-4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, rel-', u'Ketoconazole 2.0 mg/ml in Methanol', u'Tox21_110676', u'Tox21_300267', u'Tox21_500666', u'EI-107', u's1353', u'AKOS007930650', u'AB02344', u'API0003081', u'CCG-100815', u'CS-1846', u'KS-1205', u'LP00666', u'MCULE-2726394491', u'NC00065', u'MRF-0000100', u'24F2-1,25(OH)D3', u'NCGC00025000-01', u'NCGC00025000-02', u'NCGC00025000-03', u'NCGC00025000-04', u'NCGC00025000-05', u'NCGC00025000-06', u'NCGC00025000-07', u'NCGC00025000-08', u'NCGC00025000-09', u'NCGC00025000-10', u'NCGC00253967-01', u'NCGC00261351-01', u'(+/-)-cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine', u'AC-15957', u'SAM001246983', u'cis-1-Acetyl-4-[4-[[2-(2,4-', u'AB0090681', u'LS-110149', u'ST2407064', u'EU-0100666', u'K0045', u'SW196888-4', u'BIM-0050645.0001', u'J10202', u'K 1003', u'W-2941', u'277K421', u'Ketoconazole, Antibiotic for Culture Media Use Only', u'Q-201267']
- 1-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethanone
- 1-[4-(4-{[(2S,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethanone
- 1-[4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethanone
- 1-acetyl-4-(4-{[(2R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine
- Brizoral
- Cis-1-Acetyl-4-(4-((2-(2,4-Dichlorophenyl)-2-(1H-Imidazol-1-Ylmethyl)-1,3-Dioxolan-4-Yl)Methoxy)Phenyl)Piperazine
- Ethanone, 1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]-, rel-
- Fungarest
- Fungoral
- Vedi altri sinonimi
- Ketoconazol
- Ketoderm
- Ketoisdin
- Ketozoral
- Micosin
- Nizaral
- Nizoral
- Nizral
- Onofin K
- Orifungal M
- Panfungol
- Phytorol
- Piperazine, 1-acetyl-4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, rel-
- R 41400
- Tocon
- cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazole-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine
- rel-1-[4-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]ethanone
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Indagoo
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
531.4309
Formula:
C26H28Cl2N4O4
Purezza:
98%
Colore/Forma:
Solid
InChI:
InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m0/s1
InChI key:
XMAYWYJOQHXEEK-OZXSUGGESA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA: